ChiefD
Footballguy
The only problem is that the ride only lasts 8 seconds or less.People on yahoo are saying you can trade cydy on webull now.
The only problem is that the ride only lasts 8 seconds or less.People on yahoo are saying you can trade cydy on webull now.
I saw a caveat in that rule that it doesn't apply to OTC stocks. I can't remember what board I saw that on.Speaking of which, if you look back in history on short percentages, there are no days with 0% shorts from what I saw, which means that the concept that if it's down 10% or more one day, no shorting the next day doesn't seem quite accurate. Unless there's something I'm missing there.
I know that feelingThe only problem is that the ride only lasts 8 seconds or less.
Someone else had posted a link pointing out that out doesn’t eliminate shorts, it just limits what they can do.Speaking of which, if you look back in history on short percentages, there are no days with 0% shorts from what I saw, which means that the concept that if it's down 10% or more one day, no shorting the next day doesn't seem quite accurate. Unless there's something I'm missing there.
Otis is going to love the boldedWell, it was confirmed by Dr P they received correspondence from ows, but I am not sure if that means too much. Some are also saying that everyone working on Covid treatments got a letter.
Either way, we should hear in the next couple weeks.
Unfortunately, the ride on WeBear lasts a lot longer.The only problem is that the ride only lasts 8 seconds or less.
Look at all those high numbers next to our little 3.40
Look at the difference in those stock prices.
At least they added Therapies this time
I have a WeBull account and I can indeed trade it on there now. Don't think I could before.People on yahoo are saying you can trade cydy on webull now.
based off the posts I've seen, it showed up yesterday, but could not trade til todayI have a WeBull account and I can indeed trade it on there now. Don't think I could before.
I have a WeBull account and I can indeed trade it on there now. Don't think I could before.
Cydy was uplifted to the NASDAQ today. The cydy Pr team lost the notice from nasdaq and forgot the date wasn’t in two weeks.based off the posts I've seen, it showed up yesterday, but could not trade til today
***IF*** we get the uplisting, how does the shorting dynamic change
Probably volume. There should be way more institutional trading and it will be hard for a handful of shorts to make as bit of a dent in the day to day trading.***IF*** we get the uplisting, how does the shorting dynamic change?
If you think today's hard to swallow, just wait until next week, next month, and next year.I sold my CYDY at $3.18. I was happy for a 5% gain. Today has been a tough day to watch.
I'll be back at the next dip. If leronlimab does get fda approval for M2M next week it'll hurt not owning stock. But that probably has a 2% chance of happening. Otherwise, there aren't any big positive catalysts possible in the next couple of months except for possibly being uplisted to Nasdaq which isn't looking like it'll happen anytime soon either.If you think today's hard to swallow, just wait until next week, next month, and next year.
It's not to late to hop back aboard. The train is still right in front of you.
NAZ listing should be a pop esp., with the new RH buyersI'll be back at the next dip. If leronlimab does get fda approval for M2M next week it'll hurt not owning stock. But that probably has a 2% chance of happening. Otherwise, there aren't any big positive catalysts possible in the next couple of months except for possibly being uplisted to Nasdaq which isn't looking like it'll happen anytime soon either.
I think Patterson being peer reviewed and published in a respected medical journal not only gives a small bump but also really helps to stabilize it. Right now, the argument is still that their data is anecdotal, Patterson is compromised and that they had to do extensive data mining to come up with anything positive in the phase 2 trial. Getting published and being accepted better in the medical community negates a lot of that talk and actually would help with main stream media coverage too I think.I'll be back at the next dip. If leronlimab does get fda approval for M2M next week it'll hurt not owning stock. But that probably has a 2% chance of happening. Otherwise, there aren't any big positive catalysts possible in the next couple of months except for possibly being uplisted to Nasdaq which isn't looking like it'll happen anytime soon either.
On top of the above, the argument that this is a scam should start to dissolve a bit as well. Really important IMO for credibility.I think Patterson being peer reviewed and published in a respected medical journal not only gives a small bump but also really helps to stabilize it. Right now, the argument is still that their data is anecdotal, Patterson is compromised and that they had to do extensive data mining to come up with anything positive in the phase 2 trial. Getting published and being accepted better in the medical community negates a lot of that talk.
I wonder if Patterson's RANTES discovery is going to help science more than CYDY. It maybe wasn't in CytoDyn's best interests for competitors to know a potential method of combating Covid. Either way, Patterson getting published in a prestigious journal would provide a bump to stock price. But who knows if/when it'll happen. But it's really the only good catalyst that could happen soon. The S/C could conclude in 6 weeks (2 more weeks of enrollment and 4 weeks for the study). The primary endpoint is death so the results should come a day or two after unblinding. The stock will definitely plummet at some point between now and 6 weeks. It could plummet a few times in that space.Dwayne Hoover said:I think Patterson being peer reviewed and published in a respected medical journal not only gives a small bump but also really helps to stabilize it. Right now, the argument is still that their data is anecdotal, Patterson is compromised and that they had to do extensive data mining to come up with anything positive in the phase 2 trial. Getting published and being accepted better in the medical community negates a lot of that talk.
I think if the FDA denies emergency use and asks for another trial, another country will grant them emergency use and scoop up all available LL.I wonder if Patterson's RANTES discovery is going to help science more than CYDY. It maybe wasn't in CytoDyn's best interests for competitor's to know a potential method of combating Covid. Either way, Patterson getting published in a prestigious journal would provide a bump to stock price. But who knows if/when it'll happen. But it's really the only good catalyst that could happen soon. The S/C could conclude in 6 weeks (2 more weeks of enrollment and 4 weeks for the study). The primary endpoint is death so the results should come a day or two after unblinding. The stock will definitely plummet at some point between now and 6 weeks. It could plummet a few times in that space.
It would be nice for them to know, so that they would know when would be the best stage to prescribe LL. They probably can't peak right now, but they might be able to look back at the safety review.Is it possible that FDA is looking at the results for S/C to date in order to assist in decision regarding m/m EUA?
Wishful thinking but just maybe.
There is reportedly some tension between Boris Johnson and Trump which makes it more likely for the UK to try to upstage Trump. It would be a hugely popular political maneuver for Boris to buy up a bunch of leronlimab as long as it turned out to be an effective drug. Boris could come clean about taking leronlimab when he was sick.I think if the FDA denies emergency use and asks for another trial, another country will grant them emergency use and scoop up all available LL.
IMO - the longer the FDA (and other countries' NIH boards) stay quiet, the better it is for CYDY.
NEWS2 was created in the UK and is used for diagnostics on COVID over there.
I think you're a little crazy jumping out right now! But like I said, the train is still right in front of you.
Pretty sure np confirmed Boris did not take it a long time ago.There is reportedly some tension between Boris Johnson and Trump which makes it more likely for the UK to try to upstage Trump. It would be a hugely popular political maneuver for Boris to buy up a bunch of leronlimab as long as it turned out to be an effective drug. Boris could come clean about taking leronlimab when he was sick.
Thanks for showing up and screwing it all up.
Dr Yo's comments make so much more sense now, this is who he was directing it to.Also, it doesn't help that Trump immediately came down on the side of Panties.
He probably ordered a couple hundred thousand gallons of lemonadeHe probably ordered a couple hundred thousand gallons of lemonadeA couple months back, NP said there'd be a sizable amount of LL available for use by the end of August. Can't remember quantities, but want to say a couple hundred thousand vials.
We need to know if that order has been fulfilled. Unfortunately it would not surprise me if our hero effed this up too.
exactlyHe probably ordered a couple hundred thousand gallons of lemonadeHe probably ordered a couple hundred thousand gallons of lemonade
Seems like you have good insight into the way that NP's mind worksHe probably ordered a couple hundred thousand gallons of lemonadeHe probably ordered a couple hundred thousand gallons of lemonade
Doesn’t look right, should be “Officially after several months of top line proactive Nader cyto storms thread”updated title as it wasn't making sense and didn't even have any asterisks so it clearly looked like a scam
Way less fun. Sort of takes the air out from under my wings.Looks more official but less fun
Come on n00b. It’s ***OFFICIAL*** Thread not ***OFFICIAL Thread***updated title as it wasn't making sense and didn't even have any asterisks so it clearly looked like a scam
Page 1 at the moment has more not the way you listedCome on n00b. It’s ***OFFICIAL*** Thread not ***OFFICIAL Thread***
We’ve been over this before and I know for a fact they teach it in week 1 of mod class.
I believe I saw 17 million in inventory on their balance sheet.A couple months back, NP said there'd be a sizable amount of LL available for use by the end of August. Can't remember quantities, but want to say a couple hundred thousand vials.
We need to know if that order has been fulfilled. Unfortunately it would not surprise me if our hero effed this up too.